|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,550,278,644 |
|
|
Indirect Value
|
$7,642,993,607 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$10,193,272,250 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-11-12 |
4 |
B |
$2.45 |
$923,650 |
I/I |
377,000 |
11,608,760 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-11-19 |
4 |
B |
$2.65 |
$780,194 |
I/I |
294,413 |
11,903,173 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-11-21 |
4 |
B |
$2.40 |
$816,524 |
I/I |
340,900 |
12,244,073 |
1.5 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-01 |
4 |
S |
$2.84 |
$263,720 |
I/I |
(93,000) |
5,779,900 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-02 |
4 |
S |
$2.83 |
$40,271 |
I/I |
(14,207) |
5,765,693 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-06 |
4 |
S |
$2.75 |
$4,125 |
I/I |
(1,500) |
5,764,193 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-07 |
4 |
S |
$2.71 |
$17,605 |
I/I |
(6,494) |
5,757,699 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-09 |
4 |
S |
$2.69 |
$11,573 |
I/I |
(4,300) |
5,753,399 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Indirect Beneficial Owner |
|
2003-10-27 |
4 |
S |
$8.00 |
$5,968,000 |
I/I |
(746,000) |
1,455,900 |
|
- |
|
CAPS |
Capstone Therapeutics Cor... |
10% Owner |
|
2008-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,950,288 |
|
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-10 |
4 |
B |
$0.58 |
$136,753 |
I/I |
237,500 |
4,187,788 |
1.5 |
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-13 |
4 |
B |
$0.63 |
$1,638 |
I/I |
2,600 |
4,190,388 |
1.42 |
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-14 |
4 |
B |
$0.63 |
$598,083 |
I/I |
946,500 |
5,136,888 |
1.5 |
- |
|
CRIS |
Curis Inc |
10% Owner |
|
2009-02-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,921,716 |
|
- |
|
CRIS |
Curis Inc |
Indirect Beneficial Owner |
|
2009-04-27 |
4 |
S |
$1.15 |
$3,415,500 |
I/I |
(2,970,000) |
5,951,716 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
10% Owner |
|
2008-10-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,132,657 |
|
- |
|
DVAX |
Dynavax Technologies Corp |
Indirect Beneficial Owner |
|
2009-04-27 |
4 |
S |
$1.30 |
$28,600 |
I/I |
(22,000) |
8,110,657 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Indirect Beneficial Owner |
|
2009-06-03 |
4 |
S |
$1.99 |
$2,565,654 |
D/D |
(1,292,000) |
6,818,657 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Indirect Beneficial Owner |
|
2009-06-04 |
4 |
S |
$1.68 |
$847,037 |
D/D |
(505,000) |
6,313,657 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-27 |
4 |
S |
$1.99 |
$488,215 |
D/D |
(245,100) |
6,068,557 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-28 |
4 |
S |
$1.85 |
$90,665 |
D/D |
(49,000) |
6,019,557 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-29 |
4 |
S |
$1.85 |
$210,350 |
D/D |
(113,500) |
5,906,057 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-30 |
4 |
S |
$1.85 |
$28,907 |
D/D |
(15,600) |
5,890,457 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-08-05 |
4 |
S |
$2.00 |
$793,624 |
D/D |
(396,000) |
5,494,457 |
0 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-08-06 |
4 |
S |
$2.03 |
$7,103 |
D/D |
(3,500) |
5,490,957 |
0 |
- |
|
195 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|